Hereditary cerebellar ataxias with polyneuropathy
https://doi.org/10.14412/2074-2711-2015-3-75-79
Abstract
The paper gives a brief clinical characterization of hereditary cerebellar ataxias running with polyneuropathy. Particular attention is paid to the pathogenesis, clinical presentation, and treatment of gluten ataxia. A mutant gene and concurrent symptoms are indicated. The differential diagnosis of cerebellar ataxias should be started by ruling out the hereditary nature of the disease, which is verified by molecular genetic testing. In recent years, some genetic diseases manifesting themselves by a concurrence of ataxia and polyneuropathy have been replenished by a description of new hereditary syndromes. The knowledge of the nature of inheritance, age at disease onset, and concurrent manifestations will assist a practitioner in presuming the diagnosis of a rare disease and in referring a patient for medical genetic testing. Only a precise diagnosis will be able to assess prognosis and to use specific treatment.
About the Author
Svetlana Vasilyevna Kopishinskaya
Nizhny Novgorod State Medical Academy, Ministry of Health of Russia
Russian Federation
10/1 Minin and Pozharsky Sq., Nizhny Novgorod 603005
Russian Federation
10/1 Minin and Pozharsky Sq., Nizhny Novgorod 603005
References
1. Иллариошкин СН, Руденская ГЕ, Иванова-Смоленская ИА и др. Наследственные атаксии и параплегии. Москва: МЕДпресинформ; 2006. 416 с. [Illarioshkin SN, Rudenskaya GE, Ivanova-Smolenskaya IA, et al. Nasledstvennye ataksii i paraplegii [Hereditary ataxia and paraplegia]. Moscow: MEDpress-inform; 2006. 416 p.]
2. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012 Nov 14;18(42):6036-59. doi: 10.3748/wjg.v18.i42.6036.
3. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012 Feb 7;10:13. doi: 10.1186/1741-7015-10-13.
4. Hadjivassiliou M, MКki M, Sanders DS, Williamson CA. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology. 2006 Feb 14;66(3):373-7.
5. Mittelbronn M, Schittenhelm J, Bakos G, et al. CD8(+)/perforin/granzyme B(+) effector cells infiltrating cerebellum and inferior olives in gluten ataxia. Neuropathology. 2010 Feb 1;30(1):92-6. doi: 10.1111/j.1440-1789.2009.01042.x. Epub 2009 Jul 19.
6. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998 Nov 14;352(9140):1582-5.
7. Hadjivassiliou M, Sanders DS, Woodroofe N, et al. Gluten ataxia. Cerebellum. 2008;7(3):494-8. doi: 10.1007/s12311-008-0052-x.
8. Fung VS, Duggins A, Morris JG, Lorentz IT. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia. Mov Disord. 2000 Jul;15(4):732-4.
9. Tijssen MA, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology. 2000 Mar 28;54(6):1350-6.
10. Habek M, Hojsak I, Barun B, Brinar VV. Downbeat nystagmus, ataxia and spastic tetraparesis due to coeliac disease. Neurol Sci. 2011 Oct;32(5):911-4. doi: 10.1007/s10072- 011-0506-7. Epub 2011 Mar 10.
11. Hadjivassiliou M, Aeschlimann P, Strigun A, et al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008 Sep;64(3):332-43. doi: 10.1002/ana.21450.
12. Hadjivassiliou M, Boscolo S, Davies-Jones GA, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002 Apr 23;58(8):1221-6.
13. Hadjivassiliou M, Wallis LI, Hoggard N, et al. MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias. Acta Neurol Scand. 2012 Aug;126(2):138-43. doi: 10.1111/j.1600-0404.2011.01620.x. Epub 2011 Nov 10.
14. Currie S, Hadjivassiliou M, Clark MJ, et al. Should we be 'nervous' about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1216-21. doi: 10.1136/jnnp-2012-303281. Epub 2012 Aug 20.
15. Mulder CJ, van Wanrooij RL, Bakker SF, et al. Gluten-free diet in gluten-related disorders. Dig Dis. 2013;31(1):57-62. doi: 10.1159/000347180. Epub 2013 Jun 17.
16. Kaukinen K, Lindfors K, MКki M. Advances in the treatment of coeliac disease: an immunopathogenic perspective. Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):36-44. doi: 10.1038/nrgastro.2013.141. Epub 2013 Aug 6.
17. Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med. 2011 Jun;269(6):604-13. doi: 10.1111/j.1365-2796.2011.02376.x.
18. Szmulewicz DJ, McLean CA, Rodriguez ML, et al. Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS. Neurology. 2014 Apr 22;82(16): 1410-5. doi: 10.1212/WNL.0000000000000352. Epub 2014 Mar 28.
19. Lines MA, Jobling R, Brady L, et al. Peroxisomal D-bifunctional protein deficiency: three adults diagnosed by whole-exome sequencing. Neurology. 2014 Mar 18;82(11):963-8. doi: 10.1212/WNL.0000000000000219. Epub 2014 Feb 19.
20. Shimazaki H, Honda J, Naoi T, et al. Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation. J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1024-8. doi: 10.1136/jnnp-2013-306981. Epub 2014 Feb 12.
21. El Euch-Fayache G, Bouhlal Y, Amouri R, et al. Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain. 2014 Feb;137(Pt 2):402-10. doi: 10.1093/brain/awt339. Epub 2013 Dec 25.
22. Deik A, Saunders-Pullman R. Atypical presentation of late-onset Tay-Sachs disease. Muscle Nerve. 2014 May;49(5):768-71. doi: 10.1002/mus.24146. Epub 2014 Feb 24.
23. Mead S, Gandhi S, Beck J, et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013 Nov 14;369(20):1904-14. doi: 10.1056/NEJMoa1214747.
24. Koike H, Sobue G. Sjogren's syndromeassociated neuropathy. Brain Nerve. 2013 Nov;65(11):1333-42.
25. Matsufuji M, Osaka H, Gotoh L, et al. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2. Pediatr Neurol. 2013 Dec;49(6):477-81. doi: 10.1016/j.pediatrneurol.2013.07.012. Epub 2013 Oct 1.
26. Lovan A, Ihtsham ul Haq, Balakrishnan N. Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome. BMJ Case Rep. 2013 Aug 30;2013. pii: bcr2013010343. doi: 10.1136/bcr-2013-010343.
27. Swarup V, Srivastava AK, Padma MV, Rajeswari MR. Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia. J Neurosci Res. 2013 Nov;91(11):1483-91. doi: 10.1002/jnr.23262. Epub 2013 Aug 30.
28. Duquette A, Brais B, Bouchard JP, Mathieu J. Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. Mov Disord. 2013 Dec;28(14):2011-4. doi: 10.1002/mds.25604. Epub 2013 Aug 2.
29. Luigetti M, Padua L, Mazza S, et al. Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Clin Neurophysiol. 2013 Sep;124(9):1899-903. doi: 10.1016/j.clinph.2013.02.116. Epub 2013 May 1.
30. Mancuso M, Orsucci D, Angelini C, et al. Phenotypic heterogeneity of the 8344A>G mtDNA «MERRF» mutation. Neurology. 2013 May 28;80(22):2049-54. doi: 10.1212/WNL.0b013e318294b44c. Epub 2013 May 1.
31. Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol. 2013 Apr 1;5(4):a011395. doi: 10.1101/cshperspect.a011395.
32. Debs R, Froissart R, Aubourg P, et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis. 2013;36(5):859-68.
33. Lagarde J, Roze E, Apartis E, et al. Myoclonus and dystonia in cerebrotendinous xanthomatosis. Mov Disord. 2012 Dec;27(14):1805-10. doi: 10.1002/mds.25206. Epub 2012 Oct 31.
34. Hammer MB, El Euch-Fayache G, Nehdi H, et al. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families. Diagn Mol Pathol. 2012 Dec;21(4):241-5. doi: 10.1097/PDM.0b013e318257ad9a.
35. Apartis E, Blancher A, Meissner WG, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012 Oct 30;79(18):1898-907. doi: 10.1212/WNL.0b013e318271f7ff. Epub 2012 Oct 17.
36. Klebe S, Depienne C, Gerber S, et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain. 2012 Oct;135(Pt 10):2980-93. doi: 10.1093/brain/aws240.
37. Titlic M, Kodzoman K, Loncar D. Neurologic manifestations of hypereosinophilic syndrome-review of the literature. Acta Clin Croat. 2012 Mar;51(1):65-9.
38. Eiberg H, Hansen L, Korbo L, et al. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9). Clin Genet. 2012 Sep;82(3):256-63. doi: 10.1111/j.1399-0004.2011.01745.x. Epub 2011 Jul 18.
39. Regal L, Ebberink MS, Goemans N, et al. Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol. 2010 Aug;68(2):259-63. doi: 10.1002/ana.22035.
40. Perera NJ, Lewis B, Tran H, et al. Refsum's Disease - Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder. J Obes. 2011;2011. pii: 482021. doi: 10.1155/2011/482021. Epub 2010 Sep 1.
Review
For citations:
Kopishinskaya S.V. Hereditary cerebellar ataxias with polyneuropathy. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(3):75-79. (In Russ.) https://doi.org/10.14412/2074-2711-2015-3-75-79
Views: 708
Email this article 